Antisense insulin-like growth factor binding protein (IGFBP)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy

Details for Australian Patent Application No. 2001290920 (hide)

Owner The University of British Columbia

Inventors Rennie, Paul S.; Satoshi, Kiyama; Gleave, Martin; Nelson, Colleen

Agent Freehills

Pub. Number AU-B-2001290920

PCT Pub. Number WO02/22642

Priority 60232641 14.09.00 US

Filing date 13 September 2001

Wipo publication date 26 March 2002

Acceptance publication date 23 November 2006

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

23 November 2006 Application Accepted

  Published as AU-B-2001290920

22 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001290921

2001290919